8-bromo cyclic adenosine monophosphate and Arteriosclerosis

8-bromo cyclic adenosine monophosphate has been researched along with Arteriosclerosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avella, M; Botham, KM; Stevens, L1
Aoki, M; Hayashi, S; Higaki, J; Matsushita, H; Morishita, R; Nakagami, H; Nakamura, T; Ogihara, T; Taniyama, Y; Yamamoto, K1
Antonov, AS; Kabaeva, NV; Perov, NA; Petrova, LE1

Other Studies

3 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Arteriosclerosis

ArticleYear
Neutral cholesteryl ester hydrolase activity in rat peritoneal macrophages: regulation by cyclic AMP.
    Biochemical Society transactions, 1995, Volume: 23, Issue:4

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Arteriosclerosis; Bucladesine; Cyclic AMP; Foam Cells; In Vitro Techniques; Macrophages, Peritoneal; Male; Rats; Rats, Wistar; Sterol Esterase; Thionucleotides

1995
Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Aorta; Apoptosis; Arteriosclerosis; Blotting, Western; Cell Division; Cells, Cultured; Cilostazol; Colforsin; Constriction, Pathologic; Cyclic AMP; DNA Fragmentation; Gene Expression Regulation; Humans; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Proto-Oncogene Proteins p21(ras); Recombinant Proteins; Tetrazoles; Tumor Suppressor Protein p53; Vasodilator Agents

2000
[Damage to human endothelial cells by cholestane-3 beta,5 alpha,6 beta-triol and the protective effects of preparations that raise the intracellular level of cAMP].
    Tsitologiia, 1992, Volume: 34, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Adult; Aorta, Thoracic; Arteriosclerosis; Cell Survival; Cells, Cultured; Cholestanols; Colforsin; Cyclic AMP; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Humans; Middle Aged; Time Factors

1992